ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
IceCure Medical Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 17, 2026
$1.08+0.02 (+1.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 4.5
- Dividend yield
- –
Share price
−$23.38 (−95.58%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
IceCure Medical Ltd. grew revenue 2.7% to $3.38M over fiscal 2025. Free cash flow was -$14.61M.
Revenue
$3.38M
+2.7% vs. a year earlier
Operating income
-$15.09M
FY2025
Free cash flow
-$14.61M
FY2025
EPS, diluted
$0.24
-20.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- 4.5
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $3.38M
- Net income
- -$15.06M
- EPS, diluted
- $0.24
- Free cash flow
- -$14.61M
Eight years at a glance
Fiscal years 2018 to 2025, USD
Revenue
$3.38M+2.7% YoY
Gross profit
$1.23M-15.5% YoY
Operating income
-$15.09M
Net income
-$15.06M
EPS, diluted
$0.24-20.0% YoY
Free cash flow
-$14.61M
Reported period